Viatris vs Elevance Health

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (88 vs 92)
Viatris logo

Viatris

LeaderHealthcare Tech

Generic Pharmaceuticals

Viatris (VTRS) reported ~$15.4B revenue in FY2024. Global generic and specialty pharmaceutical company formed by Pfizer's Upjohn spinoff merging with Mylan. HQ: Canonsburg, PA.

AI VisibilityBeta
Overall Score
A88
Category Rank
#1 of 1
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
98
Perplexity
98
Gemini
88

About

Viatris Inc. is a global pharmaceutical company formed in 2020 through the combination of Pfizer's off-patent branded drug unit (Upjohn) and Mylan, one of the world's largest generic drug manufacturers. The company manufactures, licenses, and distributes approximately 1,400 approved molecules across branded generics, complex generics, and a portfolio of iconic off-patent brands including Lipitor (atorvastatin), Viagra (sildenafil), EpiPen, and Xanax (alprazolam) sold in markets where these brands retain meaningful recognition and premium pricing.

Full profile
Elevance Health logo

Elevance Health

LeaderHealthcare Tech

Enterprise

Indianapolis BCBS managed care (NYSE: ELV) ~$175B FY2024 revenue; Anthem renamed 2022, BCBS exclusive in 14 states, Carelon health services, Medicaid/MA medical cost pressure competing with UnitedHealth and Cigna.

AI VisibilityBeta
Overall Score
A92
Category Rank
#194 of 290
AI Consensus
68%
Trend
down
Per Platform
ChatGPT
88
Perplexity
88
Gemini
88

About

Elevance Health, Inc. (formerly Anthem, Inc.) is an Indianapolis, Indiana-based managed care and health services company — publicly traded on the New York Stock Exchange (NYSE: ELV) as an S&P 500 Health Care component — providing health insurance plans under the Blue Cross Blue Shield brand in 14 states (Indiana, Georgia, California, Colorado, Connecticut, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin), Medicare Advantage, Medicaid managed care, and commercial employer-sponsored health plans through Carelon (pharmacy and behavioral health services — formerly IngenioRx) to approximately 47 million medical members through approximately 100,000 employees. In fiscal year 2024, Elevance Health reported revenues of approximately $175 billion (predominantly premium revenues from employer-sponsored and government-program health plan members), with operating income under pressure from medical cost increases in the Medicaid segment (post-COVID health utilization normalization causing medical costs to exceed Medicaid actuarial pricing expectations set during the pandemic period of reduced care utilization). CEO Gail Boudreaux has executed the company's transformation from Anthem to Elevance Health (rebranded June 2022) — reflecting the broadened value proposition beyond health insurance into health services: Carelon Services (behavioral health, pharmacy benefit management, utilization management, home health services for both Elevance and external health plan clients) represents the strategy of building a health services ecosystem that retains value within the Elevance enterprise rather than paying external PBMs, behavioral health managers, and care management vendors.

Full profile

AI Visibility Head-to-Head

88
Overall Score
92
#1
Category Rank
#194
58
AI Consensus
68
stable
Trend
down
98
ChatGPT
88
98
Perplexity
88
88
Gemini
88
88
Claude
86
82
Grok
99

Key Details

Category
Generic Pharmaceuticals
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Viatris
Generic Pharmaceuticals

Integrations

Both integrate with
Only Elevance Health
Viatris is classified as company (part of Pfizer). Elevance Health is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.